Split Billing Between Clinic and Embryology Lab

Split billing between a fertility clinic and an embryology laboratory is one of the most operationally complex arrangements in reproductive medicine billing. When the clinical practice and the lab operate under the same tax identification number and NPI group, claim submission is straightforward — all CPT codes from a single cycle travel on claims submitted by one entity. When they operate separately — whether because the lab is a hospital-owned facility, a freestanding CLIA-certified laboratory with its own group NPI, or a physician-owned lab entity structured under a separate tax ID for liability or compliance reasons — that single IVF cycle generates two independent claim streams, two separate prior authorization requirements in many cases, two separate payer contracts, and two separate accounts receivable. Every breakdown in coordination between those two billing entities has a direct revenue consequence: unbundling violations, duplicate claim denials, authorization mismatches, and underpayment from incorrect entity billing are all predictable outcomes when the split is not structured deliberately.

Why the Split Exists: Common Structural Arrangements

The most common reason a fertility practice separates its embryology lab into a distinct billing entity is the CLIA certificate requirement. A Clinical Laboratory Improvement Amendments certificate is required for any facility that performs testing on human specimens for health assessment or the diagnosis, prevention, or treatment of disease. Embryology laboratories performing oocyte identification, fertilization, embryo culture, and cryopreservation operate under CLIA certificates of high complexity. Some practices hold the CLIA certificate under the practice's existing tax ID and bill lab services through the main practice NPI. Others establish a separate legal entity — an LLC or professional corporation — to hold the CLIA certificate and the lab's own group NPI. This structural choice drives the billing architecture: if the lab has its own group NPI enrolled with payers, lab-side CPT codes must be billed through that NPI, not the clinic's NPI.

A second common arrangement arises when the fertility practice operates within a hospital system. Hospital-employed physicians bill professional services under the physician group NPI with a professional (non-facility) place of service or a facility place of service depending on where services are rendered. The hospital's outpatient department or laboratory submits a separate facility claim for technical services using the hospital's billing entity. In this arrangement, the clinic's physicians bill CPT codes 58970 (oocyte retrieval) and 58974 (embryo transfer) as professional claims with modifier 26 when the procedure is performed in a facility, while the hospital bills the technical component of facility overhead under revenue codes on a UB-04 claim form. The embryology lab services in a hospital-based setting often appear as revenue codes rather than individual CPT codes, depending on how the hospital's charge description master is structured.

CPT Code Division: Clinic vs. Lab

The single most important operational decision in split billing is assigning each CPT code to the correct billing entity. Certain codes are inherently physician-performed and belong on the clinic's claim. Others are inherently laboratory-performed and belong on the lab's claim. A subset can go either way depending on who physically performs the service — and misassigning these creates audit exposure and potential payer recoupment. The following table identifies the standard assignment for the most commonly billed ART CPT codes:

Prior Authorization in a Split Billing Arrangement

Prior authorization for IVF and related ART services is issued at the payer's discretion, and that discretion frequently does not account for the structural reality of split billing practices. Most payers issue a single authorization tied to a specific NPI — typically the REI physician's or the clinic's group NPI. That authorization covers the physician-side CPT codes listed in the auth letter. What it often does not cover, explicitly, is the embryology lab's codes billed under a separate NPI.

• Obtain separate authorization for the lab entity: when the embryology lab bills under its own group NPI, contact the payer's prior authorization department and request authorization for lab-side CPT codes tied to the lab's NPI. Do not assume the clinical authorization covers lab services billed under a different tax ID and NPI. Many payers require the lab to be in-network independently and to hold a separate authorization for its codes.
• Verify lab network participation before each cycle: even if the clinic is in-network with a plan, the separately incorporated embryology lab may not be. Payer network directories frequently fail to list embryology labs accurately because these entities apply for and maintain credentialing on a different timeline from physician groups. Run an eligibility and network verification query using the lab's NPI — not the clinic's — against the patient's plan before the cycle begins.
• Document the authorization number on both claim sets: when a single authorization covers both clinic and lab services (less common but possible with some payers), include that authorization number on both the clinic's claim and the lab's claim. Submitting lab claims without the authorization number that the payer associated with the cycle produces a predictable denial for services not authorized.
• Track auth expiration dates for both entities independently: if the clinic obtains authorization in month one and the cycle extends into month two, the auth may expire before the lab submits its claims. Lab claims are typically submitted after embryo culture is complete, which can be 5–7 days after retrieval. Authorization validity windows must cover the lab's service dates, not just the retrieval date.

Payer-Specific Rules for Split Claims

Commercial payers approach split billing arrangements inconsistently. Some payers have developed clear policies that acknowledge separately billed lab services; others apply bundling edits that combine all ART services for a given date of service into a single allowed amount regardless of which entity bills them. Understanding the payer's policy before submitting is essential to setting accurate expectations for reimbursement.

• United Healthcare: UHC generally recognizes separately billed embryology lab services when the lab is enrolled in-network under its own NPI. However, UHC applies global period edits to IVF cycles and may bundle certain lab codes with the retrieval procedure if billed on the same date of service by different entities. Review UHC's ART clinical policy bulletin for the current code bundling matrix; it is updated annually.
• Cigna: Cigna fertility coverage is primarily managed through Cigna's fertility benefit, which often covers services only when delivered by network providers. If the embryology lab is not a separately credentialed network provider, Cigna will apply non-network cost-sharing to all lab claims regardless of the clinic's network status. Cigna's behavioral health and fertility team handles ART authorization and requires both the clinical and lab entities to be listed on the authorization request.
• Aetna: Aetna processes IVF claims through its specialty pharmacy and medical benefit structure depending on whether the practice participates in Aetna's Institutes of Excellence fertility network. Aetna generally requires the embryology lab to enroll as a distinct provider when billing under a separate NPI. Labs billing under an Aetna-contracted clinic's NPI for services actually performed at the lab location create a place-of-service mismatch that Aetna's audit team flags in post-payment review.
• Progyny: Progyny manages its own fertility benefit and has specific contracting requirements for both the clinic and the laboratory. Practices contracted with Progyny must disclose their billing structure, including whether a separately incorporated lab exists. Progyny contracts typically specify that all IVF-related services — clinical and laboratory — are billed under the single Progyny-contracted entity unless the lab has negotiated a separate Progyny contract. Submitting lab claims from an uncontraced lab entity to Progyny generally results in denial. Contact your Progyny practice relations representative to clarify the correct submission pathway for your structure.
• BCBS plans: BCBS is a federation of independent licensees, and split billing policies vary significantly across state plans. BlueCard claims (out-of-state BCBS members) add another layer of complexity: the claim routes to the member's home plan for adjudication, and that plan's ART policies — including whether it recognizes split lab billing — govern the outcome. For BlueCard ART claims, obtain the home plan's specific ART authorization and confirm whether it covers lab services billed under a separate NPI before the cycle begins.

The 26 and TC Modifier Question in Split Settings

Modifier 26 (professional component) and modifier TC (technical component) apply specifically to codes that have a physician professional component and a separate technical or facility component — they are used to split a global code into its component parts. Most embryology lab CPT codes (89250, 89254, 89268, 89280, etc.) do not carry a professional/technical split because they were written as inherently technical laboratory procedures with no separate physician interpretation component. Attempting to append modifier 26 or TC to embryology lab codes is an error — these codes are not eligible for the professional/technical component split, and payers will reject or deny claims with incorrect modifier application.

The exception involves ultrasound and certain diagnostic codes. CPT 76830 (transvaginal ultrasound) carries a global code status, meaning it can be split into a professional component (physician interpretation) and a technical component (equipment, supplies, and technician). When ultrasound monitoring during stimulation is performed in a facility where the equipment belongs to the hospital or facility rather than the clinic, the clinic bills 76830-26 for the physician's interpretation and the facility bills 76830-TC for the technical component. When the clinic owns the equipment and the physician both performs and interprets the study, the global code 76830 is billed without any modifier. Splitting 76830 into 26 and TC when the same entity owns the equipment and employs the interpreting physician results in duplicate billing — a compliance violation regardless of whether the payer pays both.

Coordination Between Clinic and Lab Billing Teams

The operational risk in split billing is not primarily about knowing which codes belong where — it is about the coordination failures that occur when two billing teams are submitting claims for the same patient's same cycle without a shared workflow. Common coordination failures include:

• Delayed lab claim submission: the clinic submits its retrieval and transfer claims immediately after the cycle; the lab submits its culture and fertilization codes days or weeks later. By the time the lab claim arrives at the payer, the cycle's authorization may have been closed in the payer's system or the coordination-of-benefits processing may have already allocated the patient's remaining benefit to the clinic's claim. Establish a shared trigger — such as a cycle closure report from the EMR — that notifies the lab billing team when the embryology phase is complete so lab claims are submitted within 5–10 business days of the last lab service date.
• Duplicate billing for the same code: both the clinic and the lab submit the same CPT code because ownership of that code was never clearly assigned. Embryo preparation (89255) and oocyte identification (89254) are the most commonly duplicated codes — some clinic teams include them on retrieval day claims while the lab team also includes them as routine line items. A written code assignment matrix that both billing teams follow eliminates this error.
• Mismatched diagnoses between clinic and lab claims: the clinic submits N97.0 (infertility due to anovulation) and the lab submits N97.9 (infertility, unspecified). When a payer crosschecks the two claims for the same patient and service period, a diagnosis mismatch triggers a medical review or denial. Standardize the ICD-10 code set for each cycle at the time of authorization and confirm that both the clinic and lab billing teams use the same primary and secondary diagnoses from that standardized list.
• Authorization number not passed to the lab: the clinic obtains authorization, records the auth number in the EMR, but never communicates it to the lab's billing team. Lab claims are submitted without the authorization number, denied for no prior auth, and the denial ages in the lab's AR without escalation. The fix is a mandatory cycle sheet — generated at authorization time — that contains the auth number, covered CPT codes, and covered dates of service, transmitted simultaneously to the clinic billing team and the lab billing team.
• Lab NPI not enrolled with the payer: the cycle proceeds and the lab submits claims under its own NPI, only to have every claim reject with "provider not found." Lab enrollment must be completed with each payer before the first claim is submitted — enrollment timelines run 60–120 days at most commercial payers, and retroactive enrollment is not possible at most plans. Audit the lab's enrollment status across all contracted payers on a quarterly basis and initiate re-enrollment proactively when a payer terminates or restructures its provider database.

Cryopreservation and Storage: Which Entity Bills

Embryo and oocyte cryopreservation and storage create a recurring billing question in split arrangements because the service has both an initial technical component (the freeze itself) and an ongoing storage component (annual cryostorage fees). CPT codes for cryopreservation include:

The cryopreservation CPT codes (89258, 89337) are laboratory services and belong on the lab's claim in a split billing arrangement. Annual storage codes (89342, 89343, 89346) are rarely covered by commercial payers and are typically billed directly to patients as a self-pay service — but when they are billed to insurance (which occurs occasionally when a patient's plan explicitly covers storage), the claim should originate from whichever entity manages physical storage of the specimens. In most practices, that is the embryology lab. Do not bill annual storage fees under the clinic's NPI if the clinic does not maintain the storage equipment — this creates a place-of-service mismatch that implies services were performed in the clinic when they were not.

Internal Audit Checklist for Split Billing Compliance

Practices operating in a split billing arrangement should conduct a quarterly audit to confirm that the structural integrity of the billing division is maintained. The following checklist is a practical starting point for that audit:

• Verify that the embryology lab's CLIA number appears on all lab claim submissions — not the clinic's CLIA number — and that the CLIA number matches the certificate currently on file with CMS for the lab's physical address.
• Pull a sample of 10–15 cycles from the quarter and map every CPT code submitted by each billing entity to the code assignment matrix. Identify any codes submitted by both the clinic and the lab for the same date of service and patient — these are duplicate billing candidates requiring correction and potential refund.
• Verify network enrollment status for the embryology lab's NPI with each payer that was billed during the quarter. For any payer where lab enrollment is pending, pull the corresponding denied claims and prepare for appeal or rebilling once enrollment is active.
• Compare authorization numbers on clinic claims versus lab claims for the same cycles. Confirm that both entities are citing the same authorization number and that the authorized CPT codes on the auth letter match the codes billed by each entity.
• Review the denial reason codes on all lab claims from the quarter. Identify any pattern of denials citing "services included in another claim" or "duplicate billing" — these indicate that the code assignment matrix is not being followed consistently by one or both billing teams.
• Confirm that place of service codes on lab claims reflect the lab's actual physical location, not the clinic's address. Claims submitted with POS 11 (office) when services were rendered at a laboratory should reflect the lab's applicable POS — typically POS 20 (urgent care facility) or POS 81 (independent laboratory) depending on how the lab is structured and enrolled.
• Review all open lab AR items older than 60 days. Identify whether the aging is concentrated in a specific payer, a specific denial reason, or a specific CPT code. Aging lab AR in split billing arrangements frequently signals an unresolved enrollment issue or a payer policy change that is rejecting the lab's NPI.

Setting Patient Financial Expectations in a Split Arrangement

One underappreciated consequence of split billing is the patient experience problem it creates. A patient whose IVF cycle is split between a clinic claim and a lab claim receives two separate Explanations of Benefits, two separate bills, and potentially two separate sets of cost-sharing obligations if the clinic and lab have different in-network contracts or different cost-sharing tiers under the patient's plan. Financial counselors must explain the split billing structure to patients before the cycle begins — not after claims have processed and the patient receives an unexpected bill from the laboratory.

The patient-facing explanation should be direct: "Your insurance will receive claims from two sources for this IVF cycle — from our clinic for the physician's services, and from our laboratory for the embryology work performed in the lab. Your insurance will process both claims and apply your deductible and out-of-pocket maximum to both. Your total out-of-pocket will reflect the combination of both sets of benefits." If the lab is out-of-network for the patient's plan and the clinic is in-network, that difference must be disclosed before the cycle — not discovered when the lab's higher cost-sharing appears on the patient's EOB. Pre-cycle financial counseling for split billing arrangements must cover both entities' network status, authorization numbers, and estimated patient responsibility separately, then present a combined estimate to the patient in writing.

Split billing between a clinic and an embryology lab is manageable — but only when both entities operate from a shared framework: a common code assignment matrix, a shared cycle data sheet, coordinated prior authorization, matched ICD-10 codes, and a quarterly audit process. The practices that do this well treat the split billing workflow as a formal operational protocol rather than an informal handoff between two independent billing teams. The practices that do it poorly absorb the consequence in predictable forms: duplicate claim denials, authorization mismatches, lab AR aging past 90 days, and patient complaints about unexpected bills. The administrative investment in building the protocol is substantially lower than the ongoing cost of managing the denials that result from the absence of one.